Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

38.50
+0.83002.20%
Post-market: 38.900.4000+1.04%19:59 EDT
Volume:1.20M
Turnover:46.61M
Market Cap:3.07B
PE:-10.25
High:39.28
Open:38.03
Low:38.00
Close:37.67
Loading ...

Akero Therapeutics Is Maintained at Buy by UBS

Dow Jones
·
01 Feb

UBS Adjusts Price Target on Akero Therapeutics to $109 From $42, Keeps Buy Rating

MT Newswires Live
·
01 Feb

89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’

TIPRANKS
·
31 Jan

Press Release: Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

Dow Jones
·
31 Jan

Stock Track | Akero Therapeutics Soars 5.76% on Analyst Upgrade and Optimistic Price Target

Stock Track
·
30 Jan

BofA Securities Upgrades Akero Therapeutics to Buy, $63 Price Target

MT Newswires Live
·
30 Jan

Akero Therapeutics Raised to Buy From Neutral by B of A Securities

Dow Jones
·
30 Jan

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates

Zacks
·
30 Jan

AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study

Zacks
·
29 Jan

Stock Track | Akero Therapeutics Soars 5.95% Following $350 Million Equity Raise and Positive Drug Study

Stock Track
·
29 Jan

BUZZ-Akero Therapeutics gains after upsized $350 mln equity raise

Reuters
·
29 Jan

Akero Therapeutics 5.333M share Secondary priced at $48.00

TIPRANKS
·
29 Jan

Akero Therapeutics Prices $350 Million Upsized Public Offering

MT Newswires Live
·
29 Jan

BRIEF-Akero Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
29 Jan

Akero Therapeutics Inc - Prices Upsized Public Offering of 5.33 Mln Shares at $48/Share

THOMSON REUTERS
·
29 Jan

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
29 Jan

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
29 Jan

Stock Track | Akero Therapeutics Soars Nearly 8% Premarket on Promising NASH Drug Data, Analyst Optimism

Stock Track
·
28 Jan

Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday

MT Newswires Live
·
28 Jan

Stock Track | Akero Therapeutics Soars 5.82% Pre-Market on Analyst Optimism for Efruxifermin Drug Candidate

Stock Track
·
28 Jan